相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment
Francesca V. Negri et al.
LIVER INTERNATIONAL (2015)
Thirty Years of Research on Met Receptor to Move a Biomarker from Bench to Bedside
Alessandro Furlan et al.
CANCER RESEARCH (2014)
Cabozantinib Suppresses Tumor Growth and Metastasis in Hepatocellular Carcinoma by a Dual Blockade of VEGFR2 and MET
Qingfeng Xiang et al.
CLINICAL CANCER RESEARCH (2014)
Leukocyte Cell-Derived Chemotaxin 2 Antagonizes MET Receptor Activation to Suppress Hepatocellular Carcinoma Vascular Invasion by Protein Tyrosine Phosphatase 1B Recruitment
Chi-Kuan Chen et al.
HEPATOLOGY (2014)
Met as a therapeutic target in HCC: Facts and hopes
Silvia Giordano et al.
JOURNAL OF HEPATOLOGY (2014)
Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth
Hannah van Malenstein et al.
CANCER LETTERS (2013)
Label-retaining liver cancer cells are relatively resistant to sorafenib
Hong-Wu Xin et al.
GUT (2013)
B-crystallin complexes with 14-3-3 to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma
Xiao-Yong Huang et al.
HEPATOLOGY (2013)
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
Hongping Xia et al.
HEPATOLOGY (2013)
Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility
Tsang-Chih Kuo et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Cancer stem cells in the development of liver cancer
Taro Yamashita et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
Armando Santoro et al.
LANCET ONCOLOGY (2013)
Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells
J-C Cheng et al.
ONCOGENE (2013)
The Enhanced Metastatic Potential of Hepatocellular Carcinoma (HCC) Cells with Sorafenib Resistance
Ariel Ka-Man Chow et al.
PLOS ONE (2013)
Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma
Julien Edeline et al.
CANCER (2012)
Fas Ligand Enhances Malignant Behavior of Tumor Cells through Interaction with Met, Hepatocyte Growth Factor Receptor, in Lipid Rafts
Huan-Ching Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Comprehensive care and care at the center of the new recommendation HAS
Elisa Derrien
ACTUALITES PHARMACEUTIQUES (2012)
Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development
Junke Zheng et al.
NATURE (2012)
Interactions between cancer stem cells and their niche govern metastatic colonization
Ilaria Malanchi et al.
NATURE (2012)
Angiopoietin-like 4 Protein Elevates the Prosurvival Intracellular O2-:H2O2 Ratio and Confers Anoikis Resistance to Tumors
Pengcheng Zhu et al.
CANCER CELL (2011)
Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2011)
Hypoxia-Inducible Factor 1 Alpha-Activated Angiopoietin-Like Protein 4 Contributes to Tumor Metastasis via Vascular Cell Adhesion Molecule-1/Integrin β1 Signaling in Human Hepatocellular Carcinoma
Hong Li et al.
HEPATOLOGY (2011)
Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
Kuen-Feng Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Twist expression promotes migration and invasion in hepatocellular carcinoma
Noriyuki Matsuo et al.
BMC CANCER (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Angiopoietin-like Protein 2 Promotes Chronic Adipose Tissue Inflammation and Obesity-Related Systemic Insulin Resistance
Mitsuhisa Tabata et al.
CELL METABOLISM (2009)
Comprehensive Analysis of the Independent Effect of Twist and Snail in Promoting Metastasis of Hepatocellular Carcinoma
Muh-Hwa Yang et al.
HEPATOLOGY (2009)
Diagnosis and treatment of hepatocellular carcinoma
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4
Kunio Matsumoto et al.
PROTEOMICS (2008)
The role of angiopoictin-like proteins in angiogenesis and metabolism
Tai Hato et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2008)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity
A Petrelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells
CC Zhang et al.
NATURE MEDICINE (2006)
Met, metastasis, motility and more
C Birchmeier et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Gene expression patterns in human liver cancers
X Chen et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis
S Jonas et al.
HEPATOLOGY (2001)
分享论文
